These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 20974253)
1. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect. Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253 [TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica/apatite nanocomposite: special synthesis route to control local drug delivery. Sousa A; Souza KC; Sousa EM Acta Biomater; 2008 May; 4(3):671-9. PubMed ID: 18206431 [TBL] [Abstract][Full Text] [Related]
3. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol. Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300 [TBL] [Abstract][Full Text] [Related]
4. Up-conversion nanoparticle assembled mesoporous silica composites: synthesis, plasmon-enhanced luminescence, and near-infrared light triggered drug release. Niu N; He F; Ma P; Gai S; Yang G; Qu F; Wang Y; Xu J; Yang P ACS Appl Mater Interfaces; 2014 Mar; 6(5):3250-62. PubMed ID: 24521281 [TBL] [Abstract][Full Text] [Related]
5. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique. Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738 [TBL] [Abstract][Full Text] [Related]
6. Mesostructured silica and aluminosilicate carriers for oxytetracycline delivery systems. Berger D; Nastase S; Mitran RA; Petrescu M; Vasile E; Matei C; Negreanu-Pirjol T Int J Pharm; 2016 Aug; 510(2):524-31. PubMed ID: 26861688 [TBL] [Abstract][Full Text] [Related]
7. Controlling drug release from mesoporous silica through an amorphous, nanoconfined 1-tetradecanol layer. Mitran RA; Matei C; Berger D; Băjenaru L; Moisescu MG Eur J Pharm Biopharm; 2018 Jun; 127():318-325. PubMed ID: 29524598 [TBL] [Abstract][Full Text] [Related]
8. Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement. Vadia N; Rajput S Eur J Pharm Sci; 2012 Jan; 45(1-2):8-18. PubMed ID: 22067974 [TBL] [Abstract][Full Text] [Related]
9. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods. Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084 [TBL] [Abstract][Full Text] [Related]
11. How Molecular Mobility, Physical State, and Drug Distribution Influence the Naproxen Release Profile from Different Mesoporous Silica Matrices. d'Orey P; Cordeiro T; Lourenço MAO; Matos I; Danède F; Sotomayor JC; Fonseca IM; Ferreira P; Correia NT; Dionísio M Mol Pharm; 2021 Mar; 18(3):898-914. PubMed ID: 33461296 [TBL] [Abstract][Full Text] [Related]
12. Release Kinetics of Nicotine Loaded onto Mesoporous Silicate Materials for Use in Nicotine Replacement Therapy. Ijbara F; Marzouqa DM; Murad A AlDamen ; Hodali HA Curr Drug Deliv; 2019; 16(10):951-958. PubMed ID: 31692442 [TBL] [Abstract][Full Text] [Related]
13. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate. Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236 [TBL] [Abstract][Full Text] [Related]
15. Characterization and release kinetics study of potato starch nanocomposite films containing mesoporous nano-silica incorporated with Thyme essential oil. Cui Y; Cheng M; Han M; Zhang R; Wang X Int J Biol Macromol; 2021 Aug; 184():566-573. PubMed ID: 34174300 [TBL] [Abstract][Full Text] [Related]
16. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release. Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268 [TBL] [Abstract][Full Text] [Related]
17. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Charnay C; Bégu S; Tourné-Péteilh C; Nicole L; Lerner DA; Devoisselle JM Eur J Pharm Biopharm; 2004 May; 57(3):533-40. PubMed ID: 15093603 [TBL] [Abstract][Full Text] [Related]
18. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623 [TBL] [Abstract][Full Text] [Related]
19. Biodegradation-tunable mesoporous silica nanorods for controlled drug delivery. Park SB; Joo YH; Kim H; Ryu W; Park YI Mater Sci Eng C Mater Biol Appl; 2015 May; 50():64-73. PubMed ID: 25746247 [TBL] [Abstract][Full Text] [Related]
20. "Graft to" Synthesis and Ibuprofen-Loading Performance of pH-Sensitive PMAA-Silica Hybrid Nanoparticles with Controlled Bimodal Mesopores. Han J; Sun J; Bai S; Panezai H; Jin X; Wu X J Pharm Sci; 2015 Dec; 104(12):4299-4306. PubMed ID: 26501935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]